Corvex plans $45M Illumina stock sale via Goldman
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ILLUMINA, INC. (ILMN) is the issuer for which Corvex Management filed a notice under Rule 144 to sell common stock. Corvex, an affiliate of a director, plans to sell up to 200,000 shares of Illumina common stock through Goldman Sachs & Co. LLC, with an aggregate market value of $44,968,000, on or after August 27, 2026, on the Nasdaq Stock Market. Illumina had 151,000,000 shares outstanding of common stock for context. Corvex states it may be deemed the beneficial owner of shares held by funds it advises, and that the shares to be sold were purchased in various open market transactions between October 25, 2023 and March 27, 2025. The notice also lists multiple prior sales of Illumina shares by Corvex-managed entities during the past three months.
Key Figures
Key Terms
Rule 144 regulatory
beneficial owner financial
aggregate market value financial
open market transactions financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Corvex Management’s Form 144 filing mean for ILLUMINA, INC. (ILMN)?
AI-generated analysis. How Rhea-AI works. Not financial advice.